🚀 European Vaccine Hub News: important milestone achieved under Pillar 3 activities - we have submitted our first phase 4 vaccine trial to CTIS, aiming to evaluate H5N8/MF59 vaccine safety and immunogenicity. Clinical sites in Antwerp (BE) and Siena (IT) are ready to start! 🌍💉 #EuropeanVaccineHub

The University of Siena has published the call for 33 positions for the PhD of National Interest in "Innovation in the Diagnosis, Prevention, and Treatment of Epidemic-Pandemic Risk Infections" for the academic year 2025-2026. 📌 Apply here: phd-dptip.unisi.it/en/home-en/ #PhD #EuropeanVaccinesHub

🇪🇺💉 #Europe boosts its #pandemic readiness with its new European Vaccine Hub in Siena, Italy. It aims for rapid vaccine development and deployment, as well as securing EU's vaccine sovereignty. Learn more here: www.ecuradio.eu/2025...#Europe#pandemic#EVH #COVID19 #Vaccine #EU #Health #Healthcare #Provax